139 related articles for article (PubMed ID: 31824430)
1. Metabolomic Assessment Reveals Alteration in Polyols and Branched Chain Amino Acids Associated With Present and Future Renal Impairment in a Discovery Cohort of 637 Persons With Type 1 Diabetes.
Tofte N; Suvitaival T; Trost K; Mattila IM; Theilade S; Winther SA; Ahluwalia TS; Frimodt-Møller M; Legido-Quigley C; Rossing P
Front Endocrinol (Lausanne); 2019; 10():818. PubMed ID: 31824430
[No Abstract] [Full Text] [Related]
2. Lipidomic analysis reveals sphingomyelin and phosphatidylcholine species associated with renal impairment and all-cause mortality in type 1 diabetes.
Tofte N; Suvitaival T; Ahonen L; Winther SA; Theilade S; Frimodt-Møller M; Ahluwalia TS; Rossing P
Sci Rep; 2019 Nov; 9(1):16398. PubMed ID: 31705008
[TBL] [Abstract][Full Text] [Related]
3. The kidney and cardiovascular outcome trials.
Bloomgarden Z
J Diabetes; 2018 Feb; 10(2):88-89. PubMed ID: 29031006
[TBL] [Abstract][Full Text] [Related]
4. Plasma Metabolomics Identifies Markers of Impaired Renal Function: A Meta-analysis of 3089 Persons with Type 2 Diabetes.
Tofte N; Vogelzangs N; Mook-Kanamori D; Brahimaj A; Nano J; Ahmadizar F; van Dijk KW; Frimodt-Møller M; Arts I; Beulens JWJ; Rutters F; van der Heijden AA; Kavousi M; Stehouwer CDA; Nijpels G; van Greevenbroek MMJ; van der Kallen CJH; Rossing P; Ahluwalia TS; 't Hart LM
J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32271379
[TBL] [Abstract][Full Text] [Related]
5. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
Koye DN; Magliano DJ; Reid CM; Jepson C; Feldman HI; Herman WH; Shaw JE
Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
[TBL] [Abstract][Full Text] [Related]
6. Decline in estimated glomerular filtration rate is associated with risk of end-stage renal disease in type 2 diabetes with macroalbuminuria: an observational study from JDNCS.
Shimizu M; Furuichi K; Toyama T; Funamoto T; Kitajima S; Hara A; Ogawa D; Koya D; Ikeda K; Koshino Y; Kurokawa Y; Abe H; Mori K; Nakayama M; Konishi Y; Samejima KI; Matsui M; Yamauchi H; Gohda T; Fukami K; Nagata D; Yamazaki H; Yuzawa Y; Suzuki Y; Fujimoto S; Maruyama S; Kato S; Naito T; Yoshimura K; Yokoyama H; Wada T;
Clin Exp Nephrol; 2018 Apr; 22(2):377-387. PubMed ID: 28889347
[TBL] [Abstract][Full Text] [Related]
7. Profiling of Plasma Metabolites Suggests Altered Mitochondrial Fuel Usage and Remodeling of Sphingolipid Metabolism in Individuals With Type 2 Diabetes and Kidney Disease.
Liu JJ; Ghosh S; Kovalik JP; Ching J; Choi HW; Tavintharan S; Ong CN; Sum CF; Summers SA; Tai ES; Lim SC
Kidney Int Rep; 2017 May; 2(3):470-480. PubMed ID: 29142974
[TBL] [Abstract][Full Text] [Related]
8. Prospective associations of circulating adipocyte fatty acid-binding protein levels with risks of renal outcomes and mortality in type 2 diabetes.
Lee CH; Cheung CYY; Woo YC; Lui DTW; Yuen MMA; Fong CHY; Chow WS; Xu A; Lam KSL
Diabetologia; 2019 Jan; 62(1):169-177. PubMed ID: 30267180
[TBL] [Abstract][Full Text] [Related]
9. Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuria.
Zobel EH; von Scholten BJ; Reinhard H; Persson F; Teerlink T; Hansen TW; Parving HH; Jacobsen PK; Rossing P
Cardiovasc Diabetol; 2017 Jul; 16(1):88. PubMed ID: 28697799
[TBL] [Abstract][Full Text] [Related]
10. High urinary sulfate concentration is associated with reduced risk of renal disease progression in type 2 diabetes.
van den Born JC; Frenay AR; Bakker SJ; Pasch A; Hillebrands JL; Lambers Heerspink HJ; van Goor H
Nitric Oxide; 2016 May; 55-56():18-24. PubMed ID: 26952289
[TBL] [Abstract][Full Text] [Related]
11. Renal outcomes with aliskiren in patients with type 2 diabetes: a prespecified secondary analysis of the ALTITUDE randomised controlled trial.
Heerspink HJ; Persson F; Brenner BM; Chaturvedi N; Brunel P; McMurray JJ; Desai AS; Solomon SD; Pfeffer MA; Parving HH; de Zeeuw D
Lancet Diabetes Endocrinol; 2016 Apr; 4(4):309-17. PubMed ID: 26774608
[TBL] [Abstract][Full Text] [Related]
12. Increased plasma concentrations of midregional proatrial natriuretic Peptide is associated with risk of cardiorenal dysfunction in type 1 diabetes.
Theilade S; Hansen TW; Goetze JP; Rossing P
Am J Hypertens; 2015 Jun; 28(6):772-9. PubMed ID: 25468806
[TBL] [Abstract][Full Text] [Related]
13. Non-albuminuric renal impairment is a strong predictor of mortality in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicentre study.
Penno G; Solini A; Orsi E; Bonora E; Fondelli C; Trevisan R; Vedovato M; Cavalot F; Lamacchia O; Scardapane M; Nicolucci A; Pugliese G;
Diabetologia; 2018 Nov; 61(11):2277-2289. PubMed ID: 30032426
[TBL] [Abstract][Full Text] [Related]
14. Urine myo-inositol as a novel prognostic biomarker for diabetic kidney disease: a targeted metabolomics study using nuclear magnetic resonance.
Kwon S; Hyeon JS; Jung Y; Li L; An JN; Kim YC; Yang SH; Kim T; Kim DK; Lim CS; Hwang GS; Lee JP
Kidney Res Clin Pract; 2023 Jul; 42(4):445-459. PubMed ID: 37551126
[TBL] [Abstract][Full Text] [Related]
15. Lixisenatide and renal outcomes in patients with type 2 diabetes and acute coronary syndrome: an exploratory analysis of the ELIXA randomised, placebo-controlled trial.
Muskiet MHA; Tonneijck L; Huang Y; Liu M; Saremi A; Heerspink HJL; van Raalte DH
Lancet Diabetes Endocrinol; 2018 Nov; 6(11):859-869. PubMed ID: 30292589
[TBL] [Abstract][Full Text] [Related]
16. High-normal levels of albuminuria predict the development of micro- and macroalbuminuria and increased mortality in Brazilian Type 2 diabetic patients: an 8-year follow-up study.
Murussi M; Campagnolo N; Beck MO; Gross JL; Silveiro SP
Diabet Med; 2007 Oct; 24(10):1136-42. PubMed ID: 17561963
[TBL] [Abstract][Full Text] [Related]
17. Serum metabolite concentrations and decreased GFR in the general population.
Goek ON; Döring A; Gieger C; Heier M; Koenig W; Prehn C; Römisch-Margl W; Wang-Sattler R; Illig T; Suhre K; Sekula P; Zhai G; Adamski J; Köttgen A; Meisinger C
Am J Kidney Dis; 2012 Aug; 60(2):197-206. PubMed ID: 22464876
[TBL] [Abstract][Full Text] [Related]
18. Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD).
Smith ER; Lee D; Cai MM; Tomlinson LA; Ford ML; McMahon LP; Holt SG
Nephrol Dial Transplant; 2013 Jun; 28(6):1569-79. PubMed ID: 23328709
[TBL] [Abstract][Full Text] [Related]
19. Contribution of cardiometabolic risk factors to estimated glomerular filtration rate decline in Indigenous Australians with and without albuminuria - the eGFR Follow-up Study.
Barr EL; Barzi F; Hughes JT; Jerums G; O'Dea K; Brown AD; Ekinci EI; Jones GR; Lawton PD; Sinha A; MacIsaac RJ; Cass A; Maple-Brown LJ
Nephrology (Carlton); 2018 Jul; 23(7):682-689. PubMed ID: 28503768
[TBL] [Abstract][Full Text] [Related]
20. Estimated glomerular filtration rate decline and risk of end-stage renal disease in type 2 diabetes.
Oshima M; Toyama T; Haneda M; Furuichi K; Babazono T; Yokoyama H; Iseki K; Araki S; Ninomiya T; Hara S; Suzuki Y; Iwano M; Kusano E; Moriya T; Satoh H; Nakamura H; Shimizu M; Hara A; Makino H; Wada T;
PLoS One; 2018; 13(8):e0201535. PubMed ID: 30071057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
